132 related articles for article (PubMed ID: 6638039)
1. Systemic, pulmonary, and coronary hemodynamic effects of labetalol in hypertensive subjects.
Mehta J; Feldman RL; Marx JD; Kelly GA
Am J Med; 1983 Oct; 75(4A):32-9. PubMed ID: 6638039
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.
Mehta J; Cohn JN
Circulation; 1977 Feb; 55(2):370-5. PubMed ID: 12880
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic effects of intravenous labetalol in essential hypertension.
Dunn FG; Oigman W; Messerli FH; Dreslinski GR; Reisin E; Frohlich ED
Clin Pharmacol Ther; 1983 Feb; 33(2):139-43. PubMed ID: 6822026
[TBL] [Abstract][Full Text] [Related]
4. Short- and long-term (six-year) hemodynamic effects of labetalol in essential hypertension.
Lund-Johansen P
Am J Med; 1983 Oct; 75(4A):24-31. PubMed ID: 6638038
[TBL] [Abstract][Full Text] [Related]
5. Haemodynamic effects of long-term oral labetalol.
Edwards RC; Raftery EB
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):733-6. PubMed ID: 791328
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of combined alpha-beta-blockade. II. Haemodynamic effects of labetalol.
Lund-Johansen P
Drugs; 1984; 28 Suppl 2():35-50. PubMed ID: 6151890
[TBL] [Abstract][Full Text] [Related]
7. Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise.
Koch G
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):725-8. PubMed ID: 10950
[TBL] [Abstract][Full Text] [Related]
8. Acute hemodynamic effects of an alpha- and beta-receptor blocking agent (AH 5158) on the systemic and pulmonary circulation at rest and during exercise in hypertensive patients.
Koch G
Am Heart J; 1977 May; 93(5):585-91. PubMed ID: 851058
[TBL] [Abstract][Full Text] [Related]
9. Effects of labetalol on systemic and pulmonary haemodynamics at rest and during exercise in hypertensive patients.
Fagard R; Amery A; Reybrouck T; Lijnen P; Billiet L
Clin Sci Mol Med Suppl; 1978 Dec; 4():279s-281s. PubMed ID: 282068
[TBL] [Abstract][Full Text] [Related]
10. Acute hemodynamic effects of labetalol in severe hypertension.
Omvik P; Lund-Johansen P
J Cardiovasc Pharmacol; 1982; 4(6):915-20. PubMed ID: 6185782
[TBL] [Abstract][Full Text] [Related]
11. Systemic and coronary hemodynamic effects of combined oral alpha- and beta-adrenergic blockade (labetalol) in normotensive patients with stable angina pectoris and positive exercise stress tests.
Feldman RL; Prida XE; Hill JA
Clin Cardiol; 1988 Jun; 11(6):383-8. PubMed ID: 3396239
[TBL] [Abstract][Full Text] [Related]
12. Systemic and coronary hemodynamics of labetalol in normotensive patients with ischemic heart disease.
Feldman RL; Prida XE; Lambert CR; Hill JA
Cardiovasc Drugs Ther; 1988 Sep; 2(3):355-61. PubMed ID: 3155428
[TBL] [Abstract][Full Text] [Related]
13. Effect of an alpha- and beta-adrenoceptor-blocking agent (labetalol) on haemodynamics in hypertension.
Bahlmann J; Brod J; Hubrich W; Cachovan M; Pretschner P
Br J Clin Pharmacol; 1979; 8(Suppl 2):113S-117S. PubMed ID: 526390
[TBL] [Abstract][Full Text] [Related]
14. Acute effect of intravenous labetalol in the treatment of systemic arterial hypertension.
Ronne-Rasmussen JO; Andersen GS; Jensen NB; Andersson E
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):805-8. PubMed ID: 990157
[TBL] [Abstract][Full Text] [Related]
15. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
Roberts DH; Tsao Y; Grimmer SF; Winstanley PA; Orme ML; Breckenridge AM
Br J Clin Pharmacol; 1987 Aug; 24(2):163-72. PubMed ID: 2887190
[TBL] [Abstract][Full Text] [Related]
16. Labetalol for the control of elevated blood pressure following coronary artery bypass grafting.
Sladen RN; Klamerus KJ; Swafford MW; Prough DS; Mann HJ; Leslie JB; Goldberg JS; Levitsky S; Molina JE; Mills SA
J Cardiothorac Anesth; 1990 Apr; 4(2):210-21. PubMed ID: 2131869
[TBL] [Abstract][Full Text] [Related]
17. Blood pressure reduction by incremental infusion of labetalol in patients with severe hypertension.
Cummings AM; Brown JJ; Fraser R; Lever AF; Morton JJ; Richards DA; Robertson JI
Br J Clin Pharmacol; 1979 Oct; 8(4):359-64. PubMed ID: 508511
[TBL] [Abstract][Full Text] [Related]
18. Labetalol infusion in acute myocardial infarction with systemic hypertension.
Marx PG; Reid DS
Br J Clin Pharmacol; 1979; 8(Suppl 2):233S-238S. PubMed ID: 526407
[TBL] [Abstract][Full Text] [Related]
19. Hemodynamic changes after acute and long-term combined alpha--beta-adrenoceptor blockade with labetalol as compared with beta-receptor blockade.
Koch G
J Cardiovasc Pharmacol; 1981; 3 Suppl 1():S30-41. PubMed ID: 6169958
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects of labetalol during halothane anaesthesia.
Scott DB; Buckley FP; Drummond GB; Littlewoods DG; Macrae WR
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):817-21. PubMed ID: 990159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
